(1) Background: Prion-like transcellular spreading of tau pathology in Alzheimer’s disease (AD) is mediated by tau binding to the cell-surface glycan heparan sulfate (HS). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.